Obesity is a global health concern. Progress in understanding the physiology of obesity and weight reduction has provided new drug targets. Development and testing of new antiobesity medications (AOMs) has the potential to quickly expand options for treatment. In this review, we briefly summarize the physiology of obesity and weight reduction, as well as medications currently approved for weight management. We highlight the increasing use of incretin and nutrient-stimulated hormone-based therapies. We conclude with an overview of AOMs progressing through the pipeline and discuss their implications for the rapidly evolving field of obesity management.

Ariana M. Chao

Simeon Taylor

Molly Moore

Anastassia Amaro

Thomas A. Wadden

The Annual Review of Pharmacology and Toxicology

自 1961 年出版的《药理学和毒理学年度评论》涵盖了药理学和毒理学领域的重大发展，包括受体、转运蛋白、酶和化学试剂；药物开发科学；免疫系统、中枢和自主神经系统、胃肠系统、心血管系统、内分泌系统和肺系统等系统；和专题。

The Annual Review of Pharmacology and Toxicology, published since 1961, covers significant developments in the fields of pharmacology and toxicology, including research on receptors, transport proteins, enzymes, and chemical agents; the science of drug development; and topics related to various systems such as the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular system, endocrine system, and pulmonary system.

《Annual Review of Pharmacology and Toxicology》自1961年出版，涵盖了药理学和毒理学领域的重要进展，包括受体、转运蛋白、酶和化学试剂的研究；药物开发的科学；以及免疫系统、中枢神经系统、自主神经系统、胃肠系统、心血管系统、内分泌系统和肺系统等多个系统的相关内容。

Category	Quartile
医学	1
医学, 药学	1
医学, 毒理学	1

Evolving Approaches for Pharmacological Therapy of Obesity

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info